文章名稱(chēng)引用次數(shù)

• A phase long-term, open-label safety study of Galcanezumab in patients with migraine27
• Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial25
• Effectiveness of rituximab in neuromyelitis optica: a meta-analysis20
• Reperfusion therapy in acute ischemic stroke: dawn of a new era?17
• Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findings16
• Pediatric multiple sclerosis: a review16
• Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease14
• Wearables for gait and balance assessment in the neurological ward - study design and first results of a prospective cross-sectional feasibility study with 384 inpatients13
• Survival and mortality in cerebral palsy: observations to the sixth decade from a data linkage study of a total population register and National Death Index13
• The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease11